financetom
Business
financetom
/
Business
/
More US companies skip lender consent to add on debt, Moody's says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
More US companies skip lender consent to add on debt, Moody's says
Aug 14, 2025 5:17 AM

Aug 14 (Reuters) - A growing number of U.S. companies

are seeking more flexible covenants in their credit agreements

to increase their debt loads while avoiding approvals from all

their existing lenders, according to a new report by ratings

agency Moody's Ratings.

Moody's said in a report released on Thursday that U.S.

corporate borrowers with weaker credit profiles were leaning

harder on their lenders to get more flexibility in agreements to

take out more debt without full consent from existing lenders,

as they struggled to issue new debt in public markets.

Deals with covenant changes that ensured a boost to a

company's capacity to raise more debt - whether for

opportunistic purposes or to avoid liquidity crunches - amounted

to as much as 40% to 300% of their EBITDA, according to

Moody's.

Such dramatic debt load increases present a major credit

risk to existing lenders, especially when borrowers' private

equity sponsors use the added debt for dividend recaps, add-ons

and acquisitions, the ratings agency noted.

Borrowers on several recent deals have sought more flexible

covenants to allow this greater debt capacity, it said, adding

that 10%, or nine of 89 credit agreements, have done so between

the start of 2024 and May 2025.

All of the 10% involved PE-backed borrowers, the report noted.

They included the initial proposed term sheets for debt that was

funding PE firm Turn/River Capital's leveraged buyout of IT

systems provider SolarWinds in March, and KKR's

leveraged buyout in May of derivatives market software

provider OSTTRA.

These recent deals point to a growing trend of borrowers'

"unfettered access" to debt, even those in financial distress,

Moody's highlighted, as lenders in the public debt market face

ever fiercer competition from lenders in the expanding private

credit market.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eupraxia Pharmaceuticals Down 2.6% After Hours as It Files for Public Offering of Common Shares
Eupraxia Pharmaceuticals Down 2.6% After Hours as It Files for Public Offering of Common Shares
Mar 10, 2026
04:37 PM EDT, 09/22/2025 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRX ) were last seen down 2.6% in after-hours Nasdaq trading after the company on Monday said it filed a preliminary prospectus supplement for a proposed public offering of its shares. The company did not say how many shares it expects to sell in the offering or at what price,...
Dave Insider Sold Shares Worth $18,812,564, According to a Recent SEC Filing
Dave Insider Sold Shares Worth $18,812,564, According to a Recent SEC Filing
Mar 10, 2026
04:33 PM EDT, 09/22/2025 (MT Newswires) -- Jason Wilk, Director, Chief Executive Officer, on September 19, 2025, sold 81,693 shares in Dave ( DAVE ) for $18,812,564. Following the Form 4 filing with the SEC, Wilk has control over a total of 265,736 Class A common shares of the company, with 217,854 shares held directly and 47,882 controlled indirectly. SEC...
Upwork Insider Sold Shares Worth $408,647, According to a Recent SEC Filing
Upwork Insider Sold Shares Worth $408,647, According to a Recent SEC Filing
Mar 10, 2026
04:36 PM EDT, 09/22/2025 (MT Newswires) -- Dave Bottoms, General Manager, Marketplace, on September 18, 2025, sold 20,908 shares in Upwork ( UPWK ) for $408,647. Following the Form 4 filing with the SEC, Bottoms has control over a total of 345 common shares of the company, with 345 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1627475/000201919425000006/xslF345X05/primarydocument.xml ...
Heartflow Receives FDA 510(k) Clearance for Next-Gen Heartflow Plaque Analysis Platform
Heartflow Receives FDA 510(k) Clearance for Next-Gen Heartflow Plaque Analysis Platform
Mar 10, 2026
04:37 PM EDT, 09/22/2025 (MT Newswires) -- Heartflow ( HTFL ) said late Monday it received US Food and Drug Administration 510(k) clearance for its next-gen Heartflow Plaque Analysis platform featuring an updated algorithm that shows a 21% improvement in plaque detection for better management and diagnosis of coronary artery disease. The latest technology also comes with an expanded nomogram...
Copyright 2023-2026 - www.financetom.com All Rights Reserved